NCT02376712

Brief Summary

The study aims to evaluate the diagnostic value of urinary indices in differentiating pre-renal and renal acute kidney injury among critically ill patients.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 25, 2015

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 3, 2015

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2015

Completed
Last Updated

March 3, 2015

Status Verified

February 1, 2015

Enrollment Period

4 months

First QC Date

February 25, 2015

Last Update Submit

March 2, 2015

Conditions

Keywords

Acute Kidney InjuryDifferential diagnosisUrinary indicesRenal Blood FlowTransesophageal Echocardiography

Outcome Measures

Primary Outcomes (1)

  • Diagnostic value of urinary indices in differentiating pre-renal and renal AKI

    Urinary indices will be compared between patient groups (pre-renal and renal AKI). Sensitivity analysis will be applied to the cut off values of renal blood flow measured by TEE. Sensitivity and specificity of the indices will be calculated. Receiver operating characteristic curves will be plotted.

    At ICU admission and during ICU stay

Secondary Outcomes (1)

  • Feasibility of measuring renal blood flow among critically ill patients

    At ICU admission and during ICU stay

Other Outcomes (2)

  • Diagnostic value of urinary indices in the subgroup of patients without diuretic use

    At ICU admission and during ICU stay

  • Diagnostic value of urinary indices in the subgroup of patients without sepsis

    At ICU admission and during ICU stay

Study Arms (2)

Pre-renal AKI

Three definitions of pre-renal AKI will be used separately: 1. Hemodynamic instability (any sign of tissue hypoperfusion) on AKI identification, and AKI recovery in 24-72 hours following hemodynamic stabilization. 2. AKI recovery in less than 72 hours after AKI identification. 3. Decreased renal blood flow measured by transesophageal echocardiography (TEE).

Renal AKI

Three definitions of renal AKI will be used separately: 1. Hemodynamically stable at AKI identification; or hemodynamically instability (any sign of tissue hypoperfusion) on AKI identification, and AKI persistence in 24-72 hours following hemodynamic stabilization. 2. AKI persistence 72 hours after AKI identification. 3. Normal or increased renal blood flow measured by TEE.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients diagnosed acute kidney injury at ICU admission or during ICU stay

You may qualify if:

  • All patients admitted to Medical ICU of PUMCH with one of the following:
  • Increase in serum creatinine by ≥ 26.5 umol/l within 48 hours;
  • Increase in serum creatinine to ≥ 1.5 times baseline, which is known or presumed to have occurred within the prior 7 days;
  • Urine volume \< 0.5ml/kg/h for 1 hour.

You may not qualify if:

  • Obstructive renal disease
  • Renal replacement therapy (RRT) for chronic kidney disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MICU of Peking Union Medical College

Beijing, 100730, China

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

Serum, urine

MeSH Terms

Conditions

Acute Kidney Injury

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • Bin Du, Dr

    MICU of Peking Union Medical College

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Medical ICU

Study Record Dates

First Submitted

February 25, 2015

First Posted

March 3, 2015

Study Start

January 1, 2015

Primary Completion

May 1, 2015

Last Updated

March 3, 2015

Record last verified: 2015-02

Locations